Gefitinib Accord

Gefitinib Accord is an oral medication used to treat certain types of cancer. This pharmaceutical is manufactured by Accord Healthcare Polska Sp. Z O.O. and is intended for oral use.

Gefitinib Accord is primarily used in the treatment of specific types of cancer. It works by targeting certain proteins in cancer cells to help slow or stop their growth. This medication is often prescribed for patients with non-small cell lung cancer that has spread or returned after prior treatment. It is important to consult with a healthcare provider to determine if Gefitinib Accord is suitable for your condition.

Common effects of Gefitinib Accord may include skin rash, diarrhea, and appetite loss. Some users may also experience dry skin, nausea, or vomiting. These effects can vary in severity and may not affect everyone who takes the medication. Always discuss any concerns with your healthcare provider.

Gefitinib Accord should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by your healthcare provider. This medication may not be suitable for everyone, especially those with certain medical conditions or allergies. Always inform your healthcare provider about any other medications you are taking.

Gefitinib Accord may interact with other medications, including certain antibiotics, antifungals, and seizure medications. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Additionally, avoid grapefruit and grapefruit juice while taking this medication, as they can affect how it works.